Skip to content

Clinical trials

Phase 3 Myotonic Dystrophy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myotonic Dystrophy Phase: Phase 3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20212
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed3
Enrolling by invitation2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lupin Ltd.4
Avidity Biosciences, Inc.3
Assistance Publique - Hôpitaux de Paris2
Dyne Therapeutics2
Grete Andersen, MD1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myotonic Dystrophy13
Myotonia4
Myotonic Disorders4
Genetic Diseases, Inborn2
Muscular Diseases2
Muscular Dystrophies2
Muscular Dystrophy, Duchenne2
Neuromuscular Diseases2
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1
Genetic Diseases, X-Linked1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.